Ocugen Inc. stock falls Tuesday, underperforms market | news.google.com • |
Ocugen Inc. stock falls Tuesday, underperforms market | news.google.com • |
Ocugen Inc. stock falls Tuesday, underperforms market | news.google.com • |
Ocugen Extends Cash Runway As OCU400 Nears Key Milestones In Phase 3 | seekingalpha.com • |
Ocugen Extends Cash Runway As OCU400 Nears Key Milestones In Phase 3 | news.google.com • |
NASDAQ: OCGN Investor Notice: Update in Lawsuit for Investors Who Lost Money With Ocugen, Inc. Shares Announced by the Shareholders Foundation | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-08 | 2024-06 | -0.06 | -0.04 | 0.02 | 33.33% |
2024-05-14 | 2024-03 | -0.06 | -0.05 | 0.01 | 16.67% |
2024-04-16 | 2023-12 | 0 | -0.04 | N/A | N/A |
2023-11-09 | 2023-09 | -0.08 | -0.06 | 0.02 | 25.00% |
2023-08-21 | 2023-06 | -0.08 | -0.1 | -0.02 | -25.00% |
2023-05-05 | 2023-03 | -0.11 | -0.07 | 0.04 | 36.36% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-30 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-08-22 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-07 | Chardan Capital | Upgrade | Buy | |
2023-04-16 | HC Wainwright & Co. | Upgrade | Buy | |
2023-04-13 | Chardan Capital | Upgrade | Buy | |
2023-02-28 | Chardan Capital | Upgrade | Neutral | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-08-10 | CASTILLO KIRSTEN M | Director | 50.00K | Sale |
2023-01-02 | CRESPO JESSICA | Officer | 163.39K | Stock Award(Grant) |
2021-05-24 | FERNANDES PRABHAVATHI | Director | 0.00 | Sale |
2021-11-01 | KOMPELLA UDAY B. | Director | 0.00 | Sale |
2022-10-05 | KUMAR RAMESH | Director | 0.00 | Sale |
2023-02-15 | MUSUNURI SHANKAR PH.D | Chief Executive Officer | 3.34M | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 11.81M | 6.41M | 4.60% |
2023-06-29 | Luminus Management, LLC | 4.08M | 2.22M | 1.59% |
2023-06-29 | GMT Capital Corp | 3.92M | 2.13M | 1.53% |
2023-06-29 | Blackrock Inc. | 3.91M | 2.12M | 1.52% |
2023-06-29 | JP Morgan Chase & Company | 3.04M | 1.65M | 1.19% |
2023-06-29 | Millennium Management Llc | 3.02M | 1.64M | 1.18% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 7.60M | 4.13M | 2.96% |
2023-06-29 | Vanguard Extended Market Index Fund | 3.06M | 1.66M | 1.19% |
2023-05-30 | Fidelity Extended Market Index Fund | 1.07M | 490.29K | 0.42% |
2023-05-30 | Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 921.56K | 423.92K | 0.36% |
2023-05-30 | Vanguard Health Care Index Fund | 738.21K | 339.58K | 0.29% |
2023-05-30 | Vanguard Russell 2000 Index Fund | 597.25K | 274.74K | 0.23% |
Split | Date |
---|---|
1 : 60 | 2019-09-30 |
-
$OCGN - 50 YEARS OF GUARANTEED REVENUES FROM COVID ANTIBODY TESTING!!!
!!!
INTERNATIONAL
APPROVAL
!!!
GLOBAL REVENUES
!!!There is an EXISTING partnership for Covid 19 testing between Ocugen and Advaite:
https://advaite.com/pipeline/diagnostics/#In case you missed it, Ocugen and Advaite are now producing COVID19 tests. There were NO PRs by Ocugen for this!
https://advaite.com/press-release/advaite-deploys-covid-19-rapid-antibody-test-kits-to-chester-county-and-collaborates-with-pennsylvania-companies-to-scale-up-manufacturing/AND, testing is ramping UP!
https://vista.today/2020/05/after-chester-county-secures-permission-covid-19-antibody-testing-to-begin-at-two-locations/Emergency Use Authorization (EUA) request for the Rapcov COVID-19 Rapid Test to the FDA (EUA # PEUA200048), currently under FDA review.
https://rapcov.com/fda-status/FDA EUA Guidelines
https://www.fda.gov/media/135659/downloadFDA CV19 Testing FAQ
https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-testing-sars-cov-2One site calls the partnership a rumor and gives insights.
https://markets.businessinsider.com/news/stocks/ocugen-stock-is-question-of-value-1029170325But, the partnership between Ocugen and Advaite is not rumor, it is fact (re: page 22 of annual report):
https://www.sec.gov/Archives/edgar/data/1372299/000110465920053502/tm2017927-1_10ka.htm
Collaboration with Advaite, Inc.
In April 2020, the Company entered into an agreement with Advaite, Inc., (Advaite) to provide certain support services for Advaite's development of a diagnostic test kit that is designed to detect antibodies to COVID-19. ...{Ocugen}... will receive tiered royalty payments based on cumulative net sales of the test kit.
*
There are literally 100s of Covid19 antibody tests. But, there is a VERY SHORT list of RELIABLE, ACCURATE antibody tests:
https://coleofduty.com/news/2020/05/11/global-covid-19-testing-market-2020-size-share-revenue-growth-supply-top-companies-and-forecast-research-2025/Again, Ocugen has contractually locked in a percentage of ALL Advaite COVID19 Antibody Tests. The revenue stream could encould exceed billions, over the next 20 years. This report answers key questions about this, with regards to Advaite and others. And, to the Ocugen CEO - masterful move sir, to guarantee an indefinite revenue stream for Ocugen like that - MASTERFUL move!
Key questions answered in this report
-
What will the market size be in 2026 and what will the growth rate be?
-
What are the key market trends?
-
What is driving this market?
-
What are the challenges to market growth?
-
Who are the key vendors in this market space?
-
What are the market opportunities and threats faced by the key vendors?
And, these test will become even MORE prevalent, moving forward, as the CDC starts the Covid Surveillance program:
https://www.cdc.gov/coronavirus/2019-ncov/covid-data/serology-surveillance/index.html -
-
-
-
-
-
-
-
-
-
-
-
What’s the best trading software for cellphone?
-
This belongs at .5?
-
So this company makes corona virus test?
-
Ok let’s get more volume
-
-
If you know someone who is penny pinching or wants to get there feet wet in the stock market, the link below will allow them to get a free share to trade. Its free money to help a friend out, especially in these times. If they sign up another they can continue to get more free shares. Not just a one time thing.
You now have a claim to a stock like Apple, Ford, or Facebook. In order to keep this claim to your stock, sign up and join Robinhood using my link. https://join.robinhood.com/johns22269
-
Ocugen Inc. stock falls Tuesday, underperforms market
news.google.com • -
Ocugen Inc. stock falls Tuesday, underperforms market
news.google.com • -
Ocugen Inc. stock falls Tuesday, underperforms market
news.google.com • -
Ocugen Extends Cash Runway As OCU400 Nears Key Milestones In Phase 3
seekingalpha.com • -
Ocugen Extends Cash Runway As OCU400 Nears Key Milestones In Phase 3
news.google.com • -
Ocugen Inc. stock rises Friday, outperforms market
news.google.com • -
Ocugen Provides Business Update with Second Quarter 2024 Financial Results
globenewswire.com • -
Ocugen, Inc. Announces Closing of $35 Million Public Offering of Common Stock
globenewswire.com • -
Ocugen, Inc. Announces Pricing of $35 Million Public Offering of Common Stock
globenewswire.com • -
Ocugen, Inc. Announces Proposed Public Offering of Common Stock
globenewswire.com • -
3 Penny Stocks That Could Turn $10K Into $100K in 3 Years
investorplace.com • -
Ocugen: Paradigm Shift Gene Therapy Facing Cash Flow Hurdles
seekingalpha.com •